Literature DB >> 35819523

Schistosoma mansoni infection decreases IL-33-mRNA expression and increases CXCL9 and CXCL10 production by peripheral blood cells.

Wheverton Ricardo Correia do Nascimento1,2, Cassia Giselle de Oliveira Nóbrega3, Erica de Souza Fernandes3, Patrícia d'Emery Alves Santos3, Fábio Lopes Melo2, Mônica Camelo Pessôa de Azevedo Albuquerque1,3, Virgínia Maria Barros de Lorena2, Vláudia Maria Assis Costa1,3, Constança Clara Gayoso Simões Barbosa2, Valdênia Maria Oliveira de Souza4,5.   

Abstract

Schistosoma mansoni infections, particularly egg antigens, induce Th2-dominant granulomatous responses accompanied by remarkable immunoregulatory mechanisms that avoid intense fibrosis. Interleukin (IL)-33 is a cytokine that stimulates the early activation of Th2 responses, and its soluble ST2 receptor (sST2) avoids granulomatous response, as well as CXCL9 and CXCL10 chemokines that have antifibrotic activity. However, in schistosomiasis, these molecules have not been suitably studied. Therefore, this study aimed to measure IL-33 and sST2 RNA, cytokines, and chemokines in peripheral blood cultures from individuals living in schistosomiasis-endemic areas. Peripheral blood cells from individuals with S. mansoni (n = 34) and non-infected individuals (n = 31) were cultured under mitogen stimulation. Supernatant chemokines and cytokines were evaluated using a cytometric bead array, and IL-33 and sST2 mRNA expression was measured using qPCR. Infected individuals showed higher levels of CXCL8, CXCL9, CXCL10, IFN-γ, TNF-α, IL-6, IL-2, IL-4, and IL-10; there was a lower expression of IL-33 mRNA and similar expression of sST2mRNA in infected than non-infected individuals. In conclusion, for the first time, we demonstrated lower IL-33mRNA expression and high levels of the antifibrotic chemokines CXCL9 and CXCL10 in schistosomiasis mansoni, which could control exacerbations of the disease in individuals from endemic areas.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CXCL10; CXCL9; IL-33; Schistosoma mansoni; sST2

Mesh:

Substances:

Year:  2022        PMID: 35819523     DOI: 10.1007/s00430-022-00745-6

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   4.148


  30 in total

1.  IL-33 mediates inflammatory responses in human lung tissue cells.

Authors:  Akiko Yagami; Kanami Orihara; Hideaki Morita; Kyoko Futamura; Noriko Hashimoto; Kenji Matsumoto; Hirohisa Saito; Akio Matsuda
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 2.  TH1/TH2 cell differentiation and molecular signals.

Authors:  Yuan Zhang; Yaguang Zhang; Wangpeng Gu; Bing Sun
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  Comparison between clinical and ultrasonographic findings in cases of periportal fibrosis in an endemic area for schistosomiasis mansoni in Brazil.

Authors:  Aluízio Prata; Raiza Ruiz-Guevara; Carlos Mauricio de Figueiredo Antunes; Carolina Coimbra Marinho; Leonardo Campos Queiroz; Izabela Voieta; José Roberto Lambertucci
Journal:  Rev Soc Bras Med Trop       Date:  2010 Mar-Apr       Impact factor: 1.581

4.  The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.

Authors:  R Kamekura; T Kojima; K Takano; M Go; N Sawada; T Himi
Journal:  Clin Exp Allergy       Date:  2012-02       Impact factor: 5.018

Review 5.  Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology.

Authors:  Candy Chuah; Malcolm K Jones; Melissa L Burke; Donald P McManus; Geoffrey N Gobert
Journal:  Trends Parasitol       Date:  2014-01-13

6.  Evaluation of serum levels of IL-9 and IL-17 in human Schistosoma mansoni infection and their relationship with periportal fibrosis.

Authors:  Ana Virgínia Matos Sá Barreto; Glaucia Alyne Nunes de Lacerda; Anna Lígia de Castro Figueiredo; George Tadeu Nunes Diniz; Elainne Christine Souza Gomes; Ana Lúcia Coutinho Domingues; Constança Simões Barbosa; Silvia Maria Lucena Montengro; Clarice Neuenschwander Lins de Morais
Journal:  Immunobiology       Date:  2016-08-01       Impact factor: 3.144

7.  Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.

Authors:  Andrew M Tager; Richard L Kradin; Peter LaCamera; Scott D Bercury; Gabriele S V Campanella; Carol P Leary; Vasiliy Polosukhin; Long-Hai Zhao; Hideo Sakamoto; Timothy S Blackwell; Andrew D Luster
Journal:  Am J Respir Cell Mol Biol       Date:  2004-06-17       Impact factor: 6.914

8.  Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.

Authors:  Hiroko Hayakawa; Morisada Hayakawa; Akihiro Kume; Shin-ichi Tominaga
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

Review 9.  Immunology of human schistosomiasis.

Authors:  D G Colley; W E Secor
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

10.  A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.

Authors:  S Wilson; F M Jones; H K M Fofana; A Landouré; G Kimani; J K Mwatha; M Sacko; B J Vennervald; D W Dunne
Journal:  Parasite Immunol       Date:  2013-07       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.